Vogenx Inc
NAS:VOGXHealth Technologynasdaq_composite$15.92+9.57%At closeAt close · Tue 20 Oct · ≈ AED 58.47 · Market cap $236.49M · Next earnings Wed 2 Dec
| USD millions | FY2024 | FY2025 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Cost of revenue | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 |
| Research & development | 1.3 | 0.6 |
| Operating expenses | 2.3 | 1.4 |
| Operating income | (2.3) | (1.4) |
| Interest expense | 0.0 | — |
| Interest income | 0.0 | 0.0 |
| Pre-tax income | (2.2) | (1.4) |
| Income tax | 0.0 | 0.0 |
| Net income | (2.2) | (1.4) |
| EPS, basic (per share) | (0.15) | (0.10) |
| EPS, diluted (per share) | (0.15) | (0.10) |
| EBITDA | (2.3) | (1.4) |
| Weighted average shares (shares) | 14,855,087 | 14,855,087 |
| Weighted average diluted shares (shares) | 14,855,087 | 14,855,087 |
USD millionsUpdated Thu 17 Sep ·
ⓘ
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
